Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Describing the resource utilisation and costs associated withvertebral fractures: the Build Better Bones with Exercise (B3E) Pilot Trial.
Hassan S, Seung SJ, Clark RE, Gibbs JC, McArthur C, Mittmann N, Thabane L, Kendler D, Papaioannou A, Wark JD, Ashe MC, Adachi JD, Templeton JA, Giangregorio LM. Hassan S, et al. Among authors: templeton ja. Osteoporos Int. 2020 Jun;31(6):1115-1123. doi: 10.1007/s00198-020-05387-z. Epub 2020 Mar 26. Osteoporos Int. 2020. PMID: 32219499 Clinical Trial.
Build better bones with exercise (B3E pilot trial): results of a feasibility study of a multicenter randomized controlled trial of 12 months of home exercise in older women with vertebral fracture.
Giangregorio LM, Gibbs JC, Templeton JA, Adachi JD, Ashe MC, Bleakney RR, Cheung AM, Hill KD, Kendler DL, Khan AA, Kim S, McArthur C, Mittmann N, Papaioannou A, Prasad S, Scherer SC, Thabane L, Wark JD. Giangregorio LM, et al. Among authors: templeton ja. Osteoporos Int. 2018 Nov;29(11):2545-2556. doi: 10.1007/s00198-018-4652-0. Epub 2018 Aug 8. Osteoporos Int. 2018. PMID: 30091064 Clinical Trial.
Exercise for improving outcomes after osteoporotic vertebral fracture.
Gibbs JC, MacIntyre NJ, Ponzano M, Templeton JA, Thabane L, Papaioannou A, Giangregorio LM. Gibbs JC, et al. Among authors: templeton ja. Cochrane Database Syst Rev. 2019 Jul 5;7(7):CD008618. doi: 10.1002/14651858.CD008618.pub3. Cochrane Database Syst Rev. 2019. PMID: 31273764 Free PMC article.
Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial.
Mangin D, Lamarche L, Agarwal G, Banh HL, Dore Brown N, Cassels A, Colwill K, Dolovich L, Farrell B, Garrison S, Gillett J, Griffith LE, Holbrook A, Jurcic-Vrataric J, McCormack J, O'Reilly D, Raina P, Richardson J, Risdon C, Savelli M, Sherifali D, Siu H, Tarride JÉ, Trimble J, Ali A, Freeman K, Langevin J, Parascandalo J, Templeton JA, Dragos S, Borhan S, Thabane L. Mangin D, et al. Among authors: templeton ja. Trials. 2021 Oct 26;22(1):746. doi: 10.1186/s13063-021-05685-9. Trials. 2021. PMID: 34702336 Free PMC article.
Team approach to polypharmacy evaluation and reduction: feasibility randomized trial of a structured clinical pathway to reduce polypharmacy.
Mangin D, Lamarche L, Agarwal G, Ali A, Cassels A, Colwill K, Dolovich L, Brown ND, Farrell B, Freeman K, Frizzle K, Garrison SR, Gillett J, Holbrook A, Jurcic-Vrataric J, McCormack J, Parascandalo J, Richardson J, Risdon C, Sherifali D, Siu H, Borhan S, Templeton JA, Thabane L, Trimble J. Mangin D, et al. Among authors: templeton ja. Pilot Feasibility Stud. 2023 May 18;9(1):84. doi: 10.1186/s40814-023-01315-0. Pilot Feasibility Stud. 2023. PMID: 37202822 Free PMC article.
Theoretical Underpinnings of a Model to Reduce Polypharmacy and Its Negative Health Effects: Introducing the Team Approach to Polypharmacy Evaluation and Reduction (TAPER).
Mangin D, Lamarche L, Templeton JA, Salerno J, Siu H, Trimble J, Ali A, Varughese J, Page A, Etherton-Beer C. Mangin D, et al. Among authors: templeton ja. Drugs Aging. 2023 Sep;40(9):857-868. doi: 10.1007/s40266-023-01055-z. Epub 2023 Aug 21. Drugs Aging. 2023. PMID: 37603255 Free PMC article.
14 results